Skip to main content

Type II acquired cutis laxa associated with recurrent urticarial vasculitis: brief report

Abstract

Background

Cutis laxa is a connective tissue disease characterized by loose, wrinkled, and redundant skin. It is either inherited or acquired. In most cases, acquired cutis laxa is associated with neoplasms, drugs, and autoimmune diseases. We present a rare case of acquired cutis laxa following a recurrent urticaria-like eruption in the absence of an autoimmune disease, neoplasm, drugs and or syndrome.

Case presentation

We report a case of a 45-year-old Chinese lady with a 1-year history of widespread pruritic urticarial eruption and a 6-month history of progressive skin wrinkling. On examination, the patient appeared older than her actual age, with apparent wrinkling on the mid-torso with generalized smooth, erythematous macules and wheals. A family history of similar conditions was absent. Biopsy revealed hypersensitivity and atrophy. Following the Food and Drug Administration (FDA) guidelines, we administered antihistamines, which relieved the itching, but her hyperpigmentation and cutis laxa never improved.

Conclusion

Our case shows that the decrease of elastic fibers may be associated with the infiltration of inflammatory cells in the dermis. This supports the hypothesis that chemical mediators may play a major role in the destruction of elastic fibers, thus causing cutis laxa. In addition, we advise practitioners to take a complete clinical and family history to determine if the condition is inherited or acquired.

Background

Acquired cutis laxa is a phenotype of cutis laxa affecting dermal elastin [1]. It has two forms; type I and type II. Type I can either be localized or generalized involving visceral organs, such as respiratory, cardiovascular, gastrointestinal, and genitourinary systems [2, 3]; elasticity of the skin in type I can be observed both in inflammatory and non-inflammatory areas. Type II is localized post-inflammatory elastolysis, where skin elasticity occurs over the inflammatory area without involving visceral organs [4, 5]. It is seen mostly in adults; onset is abrupt mainly with a cephalocaudal predisposition [3]. We present a case of a 45-year-old Chinese lady with progressing skin wrinkling after the urticaria-like eruption. To our knowledge, this is the first case documenting acquired cutis laxa following urticarial vasculitis in the absence of an autoimmune disease, neoplasm, drugs, and syndrome.

Case presentation

Our patient, a 45-year-old Chinese lady, was healthy up until February 2017, when she presented to a clinic in her hometown with generalized, pruritic, mildly painful, erythematous macules and wheals all over her body. They noted lesions persisted for 2–3 days and left hyperpigmented marks on disappearing. They diagnosed her with chronic urticaria, which was controlled with oral antihistamines. Around October 2017, her skin had become atrophic, loose, and sagging, specifically around her mid-torso region. The local clinic continued her on antihistamines for the urticarial wheals, and they advised her that once urticarial wheals improved, the skin would go back to normal. With no change in symptoms, the patient was then referred to our hospital.

The patient came to us in March 2018, with a chief complaint of a 1-year history of widespread pruritic urticarial eruption and a 6-month history of progressive skin wrinkling, which gave her an aged appearance. She reported no family history of a similar condition. On examination, the 45-year-old lady appeared older than her actual age, with loose, saggy, and wrinkled skin on the anterior and posterior trunk. She had multiple 2–5 cm of smooth, erythematous wheals on the upper extremities, and extensive skin atrophy and hyperpigmentation on the trunk (Fig. 1). She had unilateral right supraclavicular (14.4 * 5.6 mm), bilateral cervical (R = 19.9 * 5.4 mm, L = 13.4 * 5.9 mm), auxiliary (R = 14.4 * 4.6 mm, L = 16.2 * 6.7 mm) and inguinal (R = 27.9 * 4.1 mm, L = 17.0 * 4.1 mm) swelling of lymph nodes. No fever, joint and bone pain.

Fig. 1
figure 1

Showing clinical picture. a Erythematous wheals on the elbow, extending towards the upper arm. b–d Skin atrophy, wrinkles, and hyperpigmentation on the lateral and anterior side of the torso, respectively. ① and ②, sites for biopsy

Incision biopsy for hematoxylin–eosin (HE) and Verhoeff-van Gieson stain was done from the right-side flank and showed neutrophilic infiltration of the interstitial dermis and extravasated erythrocytes. Biopsy also revealed decreased elasticity of dermal tissue with clustered fibers or fragmented with infiltrated inflammatory changes in collagen. There was a breakdown of erythrocytes, peripheral nerve infiltration, deposition of elastin, and separation of collagen bundles confirmed the diagnosis (Fig. 2).

Fig. 2
figure 2

Showing histology findings. a (From biopsy site â‘ ) and b (from biopsy site â‘¡), multiple neutrophils, with few eosinophils and no edema with deposition of elastin and collagen bundle fragmentation in deep dermis (HE × 200). c (From biopsy site â‘ ) and d (from biopsy site â‘¡) dispersed elastin showing an amorphous substance and fragmentation of elastic fibers positive with Verhoeff-van Gieson stain (× 400)

Additional examination included; blood test: Neutrophils = 38.5% (normal range is 40–75%), lymphocytes = 54.9% (normal range is 20–50%). White blood cell 4.06 G/L (normal range is 3.5–9.5 g/L), alpha antitrypsin (109 mg/mL), urine test, fecal test, ESR, liver, and kidney function tests, tb-ab, T-SPOT, ANA test, ANCA, and serum complement test (s) were normal. IgG 7.36 g/L (normal range 7.3–15.6 g/L), IgA I.35 (normal range 0.82–4.53 g/L), IgE 191.6 IU/mL (normal range 1–190 IU/mL), IgM 8.91 g/L (normal range 0.46–3.04 g/L), CRP 18.9 mg/L (normal range is < 8.00 mg/L) and KTG test (167.2).)

Discussion and conclusion

Acquired cutis laxa may be associated with autoimmune diseases such as systemic lupus erythematosus, inflammatory processes including chronic urticaria, and urticarial vasculitis, as well as reduced alpha antitrypsin [5, 6]. The proposed mechanism by which these factors are associated with acquired cutis laxa revolves around the loss of elastic fibers [1, 7]. An immune-mediated mechanism has also been postulated to cause cutis laxa [4, 8], in which case the activated neutrophils produce elastase, which breaks down collagen fibers and induces elastolysis [7, 9]. Our patients had elevated levels of CRP, IgE, and IgM. Elevated IgE is consistent with an allergic reaction, while elevated CRP and IgM are consistent with an acute infection that induced lymphadenopathy. Additionally, histopathology showed neutrophilic infiltration between collagen fibers and leukocytoclasia around blood vessels, which are the characteristic features of acquired cutis laxa [1]. According to published literature, autoimmune diseases deposit immunoglobulins in the dermis, which causes the destruction of elastic tissue resulting in acquired cutis laxa [3, 10]; however, in this case, the acquired cutis laxa followed an inflammatory condition.

A few authors reported acquired cutis laxa after urticarial vasculitis; however, it was in the setting of an autoimmune disease such as systemic lupus erythematosus, IgA myeloma [3, 11]; but our patient presented with loose, saggy, and wrinkled skin on the anterior and posterior trunk without systemic symptoms. Although these are symptoms of cutis laxa, they can overlap with other diseases such as mid-dermal elastolysis, which presents with erythema reticulated plaques with patches of fine wrinkling [12]. Granulomatous slack skin may also present in the same way as acquired cutis laxa, but it is characterized by painless purple plaques and redundant sagging skin [13].

The relationship between acquired cutis laxa and urticaria-like eruption is still not clear. Moreover, Fornieri C et al. stated that the increase in protein elastin turn-over and reduction of serum alpha antitrypsin by fibroblasts increases elastolytic activity [1]. However, our case differs from Fornieri et al. findings since the acquired cutis laxa occurred after urticaria-like skin lesions without an underlying systemic condition. Therefore, we propose that future research should focus on chemical mediators involved in the breakdown of elastic fibers, which causes elastolysis. Finally, it’s crucial to get a complete history to determine if the condition is systemic or acquired.

Availability of data and materials

All data and materials can be obtained by email to the corresponding author.

Abbreviations

ESR:

erythrocyte sedimentation rate

T-SPOT:

tuberculosis-spot

ANA:

antinuclear antibody

ANCA:

antineutrophil cytoplasmic antibodies

SLE:

systemic lupus erythematosus

IgG:

immunoglobulin G

IgM:

immunoglobulin M

IgA:

immunoglobulin A

CRP:

C-reactive protein

KTG:

kinetic turbidimetric (1,3) beta-d-glucan detection

HE:

hematoxylin–eosin

References

  1. Fornieri C, Quaglino D, Lungarella G, Cavarra E, Tiozzo R, Giro MG, et al. Elastin production and degradation in cutis laxa acquisita. J Invest Dermatol. 1994;103(4):583–8.

    Article  CAS  Google Scholar 

  2. Siqueira MF, Ministerio PA, Valadares ER, Purisch S, Bambirra EA, Pardini VC. Cutis laxa associated to cardiac failure. J Pediatr (Rio J). 1999;75(1):63–8.

    Article  CAS  Google Scholar 

  3. Golisch KB, Gottesman SP, Ferrer P, Culpepper KS. Cutis laxa acquisita after urticarial vasculitis in SLE patients. Am J Dermatopathol. 2018;40(6):433–7.

    Article  Google Scholar 

  4. Chun SI, Yoon J. Acquired cutis laxa associated with chronic urticaria. J Am Acad Dermatol. 1995;33(5 Pt 2):896–9.

    Article  CAS  Google Scholar 

  5. Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: part II. Decreased elastic tissue. J Am Acad Dermatol. 2004;51(2):165–85.

    Article  Google Scholar 

  6. Sun T, Evans HE, Degnan T. Acquired alpha-1-antitrypsin deficiency and dysgammaglobulinemia. Ann Clin Lab Sci. 1980;10(2):149–54.

    CAS  PubMed  Google Scholar 

  7. Reed WB, Horowitz RE, Beighton P. Acquired cutis laxa. Primary generalized elastolysis. Arch Dermatol. 1971;103(6):661–9.

    Article  CAS  Google Scholar 

  8. Lewis PG, Hood AF, Barnett NK, Holbrook KA. Postinflammatory elastolysis and cutis laxa. A case report. J Am Acad Dermatol. 1990;22(1):40–8.

    Article  CAS  Google Scholar 

  9. Schwartz E, Cruickshank FA, Lebwohl MG. Elastase-like protease and elastolytic activities expressed in cultured dermal fibroblasts derived from lesional skin of patients with Pseudoxanthoma elasticum, actinic elastosis, and cutis laxa. Clin Chim Acta. 1988;176(2):219–24.

    Article  CAS  Google Scholar 

  10. Demitsu T, Kakurai M, Azuma R, Hiratsuka Y, Umemoto N, Yoneda K. Neutrophilic, urticaria-like erythema associated with immunoglobulin A monoclonal gammopathy of undetermined significance. J Dermatol. 2008;35(5):293–6.

    Article  Google Scholar 

  11. Turner RB, Haynes HA, Granter SR, Miller DM. Acquired cutis laxa following urticarial vasculitis associated with IgA myeloma. J Am Acad Dermatol. 2009;60(6):1052–7.

    Article  Google Scholar 

  12. Gambichler T. Mid-dermal elastolysis revisited. Arch Dermatol Res. 2010;302(2):85–93.

    Article  Google Scholar 

  13. Goldsztajn KO, Moritz Trope B, Ribeiro Lenzi ME, Cuzzi T, Ramos ESM. Granulomatous slack skin. Histopathology diagnosis preceding clinical manifestations by 12 years. J Dermatol Case Rep. 2012;6(4):108–12.

    Article  Google Scholar 

Download references

Acknowledgements

National Natural Science Foundation of China for the financial support.

Statement on any prior presentation

None.

Reprint requests

Chang Zheng Huang.

Limitations

None.

Funding

This work was supported partially by grants from the National Natural Science Foundation of China (No. 81472886 to Changzheng Huang).

Author information

Authors and Affiliations

Authors

Contributions

CH made the diagnosis and provided additional information on differential diagnosis; SD interpreted all patient’s data from history to when patient was admitted to our hospital, AN approved of care and wrote a manuscript, MM had the role of overall editing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Changzheng Huang.

Ethics declarations

Ethics approval and consent to participate

An informed and written consent was obtained from the patient prior to publication.

Consent for publication

This case report was approved and obtained by the institutional review board at Huazhong University of Science and Technology, Union Hospital.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nabatanzi, A., Da, S., Male, M. et al. Type II acquired cutis laxa associated with recurrent urticarial vasculitis: brief report. Allergy Asthma Clin Immunol 16, 1 (2020). https://doi.org/10.1186/s13223-019-0401-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13223-019-0401-y

Keywords